Christian Carlos Zurita‐Lizza, Ignacio Rodriguez‐Sanchez, & Pablo Alexis Doreski. (2023). Repurposing Inhaled Ibuprofenate, a Non Steroidal Anti‐Inflammatory Drug, as a Potential Adjuvant Treatment for Pneumonia, CARDS and its Aetiological Agent SARS‐CoV‐2. Wiley.
Chicago Style (17th ed.) CitationChristian Carlos Zurita‐Lizza, Ignacio Rodriguez‐Sanchez, and Pablo Alexis Doreski. Repurposing Inhaled Ibuprofenate, a Non Steroidal Anti‐Inflammatory Drug, as a Potential Adjuvant Treatment for Pneumonia, CARDS and Its Aetiological Agent SARS‐CoV‐2. Wiley, 2023.
MLA (9th ed.) CitationChristian Carlos Zurita‐Lizza, et al. Repurposing Inhaled Ibuprofenate, a Non Steroidal Anti‐Inflammatory Drug, as a Potential Adjuvant Treatment for Pneumonia, CARDS and Its Aetiological Agent SARS‐CoV‐2. Wiley, 2023.